Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 49.0337
Recommendation STRONG BUY
P/E 2.05
ROE 21.93 %
Capitalization 379,704,510 $
Dividend Yield 0.00 %
P/S 1.19
AII Position 45
P/E Position 2
ROE Position 133
Capitalization Position 729
Dividend Yield Position 598
Sales 320,060,000 $
10-Year Average Earnings 185,490,200 $
Shares Outstanding 156,257,000
Equity 845,890,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2017 12 320,060,000.00 $
2016 12 244,301,000.00 $
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 110,748,000.00 $
2016 12 63,606,000.00 $
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $
2008 12 68,387,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 845,890,000.00 $
2016 12 755,423,000.00 $
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 156,257,000
2016 12 164,192,000
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:



Google News for PDL BIOPHARMA:

Zacks.com - 22 hours ago
Is PDL BioPharma (PDLI) a Great Stock for Value Investors?
Clearly, PDLI is a solid choice on the value front from multiple angles. ... Though PDL BioPharma might be a good choice for value investors, ...
AppsforPCdaily
SevenSaoi Capital delivers letter to the board of PDL Biopharma
SevenSaoi Capital, LLC has delivered a letter to the Board of Directors of PDL BioPharma (NASDAQ:PDLI). The letter, addresses SevenSaoi's ...
NMSU Nеws
UPDATE: SevenSaoi Capital LLC Provides Letter to PDL ...
UPDATE: SevenSaoi Capital LLC Provides Letter to PDL BioPharma (PDLI) Board Highlighting 'Serious Concerns with Company's Failed ...
Emn News
PDL BioPharma Inc. (PDLI) Moves Lower on Volume Spike for ...
PDL BioPharma Inc. (PDLI) traded on unusually high volume on Sep. 21, as the stock lost 0.82% to close at $2.43. On the day, PDL BioPharma ...
Seeking Alpha - 1 day ago
Why Is PDL BioPharma (PDLI) Up 2.5% Since Last Earnings Report?
Will the recent positive trend continue leading up to its next earnings release, or is PDL BioPharma due for a pullback? Before we dive into how ...
StreetInsider.com - 1 day ago
Reviewing PDL BioPharma (PDLI) & Vericel (VCEL)
PDL BioPharma (NASDAQ: VCEL) and Vericel (NASDAQ:VCEL) are both small-cap medical companies, but which is the superior business?
PressOracle
Analysts Speculate on Pdl Biopharma Inc (PDLI)
Pdl Biopharma Inc (NASDAQ:PDLI) shares traded down -1.29% during most recent session. Wall Street analysts covering the stock are ...
NMSU Nеws
Microbot Medical (MBOT) & PDL BioPharma (PDLI) Critical Survey
PDL BioPharma (NASDAQ: MBOT) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior ...
Nasdaq Click (press release)
Pdl Biopharma $PDLI Technical Update
The Pdl Biopharma (NASDAQ: PDLI) update and the technical summary table below can help you manage risk and optimize returns. We have ...
Equities.com - 13 hours ago
Brandes Investment Partners LP Has $638000 Holdings in PDL ...
Brandes Investment Partners LP decreased its holdings in PDL BioPharma Inc (NASDAQ:PDLI) by 66.8% during the 2nd quarter, according to ...


Back